Coeptis Therapeutics, Inc.
NASDAQ:COEPBiotechnology
Healthcare
$14.64 +4.68%
+$0.73 today
- Market cap
- $57.63M
- Beta
- -0.43
- P/E (TTM)
- -8.3
- EPS (TTM)
- -$1.97
52W Low $6.80High $21.41
Volume 0.18M
Average 0.05M
Balance Sheet
Inspect the capital base behind the business.
Assets
$19.84M
FY 2025 · Annual
+122.7% YoYLiabilities
$2.09M
FY 2025 · Annual
-58.6% YoYEquity
$17.75M
FY 2025 · Annual
+359.1% YoYBalance Sheet
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 2.18M | 3.79M | 1.47M | 532.89K | 5.67M |
| Short-term Investments | 0 | 0 | 0 | 0 | 676.6K |
| Net Receivables | 0 | 8.08K | 38.98K | 0 | 7.35K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 2.18M | 3.94M | 1.75M | 1.05M | 7.35M |
| Property, Plant & Equipment (Net) | 31.85K | 71.46K | 108.88K | 59.78K | 18.4K |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.55M | 3.55M | 2.55M | 541.88K | 361.25K |
| Long-term Investments | 0 | 0 | 3.5M | 5.69M | 7.86M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 4.55M | 348.33K | 158.33K | 1.56M | 4.25M |
| Total Non-current Assets | 4.59M | 3.97M | 6.32M | 7.86M | 12.49M |
| Total Assets | 6.77M | 7.92M | 8.07M | 8.91M | 19.84M |
| Account Payables | 134.09K | 99.02K | 1.42M | 1.27M | 888.76K |
| Short-term Debt | 2.42M | 1.89M | 1.01M | 1.19M | 118.88K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 599.46K |
| Other Current Liabilities | 199.13K | 182K | 555.95K | 1.28M | 161.05K |
| Total Current Liabilities | 2.76M | 2.17M | 2.99M | 4.51M | 1.77M |
| Long-term Debt | 1.65M | 150K | 150K | 150K | 150K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 1.13M | 557.25K | 359.25K | 167.63K |
| Total Non-current Liabilities | 1.65M | 1.29M | 768.43K | 528.13K | 317.63K |
| Total Liabilities | 4.41M | 3.46M | 3.76M | 5.04M | 2.09M |
| Common Stock | 3.55K | 1.96K | 3.53K | 212 | 575 |
| Retained Earnings | (27.55M) | (66.09M) | (87.36M) | (98.23M) | (109.95M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | (1.56M) | 0 |
| Minority Interest | 0 | 0 | 0 | 682.06K | 506.16K |
| Total Equity | 2.35M | 4.45M | 4.31M | 3.87M | 17.75M |
| Total Debt | 4.08M | 2.06M | 1.22M | 1.4M | 268.88K |
| Net Debt | 1.9M | (1.73M) | (244.91K) | 866.17K | (5.41M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $5.2M |
| Short-term Investments | $50.6K |
| Receivables | $15.3K |
| Other Current | $631.1K |
| Total Current Assets | $5.9M |
| PP&E (Net) | $89.3K |
| Intangible Assets | $316.1K |
| Long-term Investments | $13.2M |
| Other Non-current | $313.9K |
| Total Non-current Assets | $13.9M |
| Total Assets | $19.8M |
Analysis
Selected assets total $19.8M for Latest. The largest visible component is Long-term Investments at $13.2M, about 66.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 424B3 | 424B3 filing | Jun 18, 2026 | |
| EFFECT | EFFECT filing | Jun 16, 2026 | |
| POS AM | POS AM filing | Jun 16, 2026 | |
| S-1 | S-1 filing | Jun 9, 2026 | |
| 4 | Statement of changes in beneficial ownership | Jun 8, 2026 |
How much cash does COEP have?
Coeptis Therapeutics, Inc. (COEP) reported $5.67M in cash and equivalents in fiscal 2025.
How much debt does COEP carry?
Coeptis Therapeutics, Inc. (COEP) reported $268,875.00 of total debt, with net debt of -$5.41M.
Continue the stock analysis
Jump to another research area for this company.